Acrostak
Acrostak is a Swiss medical device company that designs and manufactures specialized balloon catheters and microcatheters for interventional cardiologists performing PCI and chronic total occlusion procedures worldwide.
- Company typePrivate
- Founded2001
- HeadquartersGeneva, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Acrostak does
Acrostak (Schweiz) AG is a Swiss medical device company founded in 2001 and headquartered at Stegackerstrasse 14 in Winterthur, Switzerland. The company designs, manufactures, and commercializes specialized interventional cardiology devices — specifically balloon catheters and microcatheters used in percutaneous coronary intervention (PCI) and the treatment of chronic total occlusions (CTOs). Its product portfolio is organized into four categories: CTO balloons (Across CTO, Across CTO ST), PTCA balloons (Across HP semi-compliant and Across NC non-compliant), specialty balloons (Grip and Grip TT, featuring proprietary metal-free polymer technology), and the M-Cath Flexy microcatheter with a three-section braided shaft. Differentiated technical features include first-to-market metal-free polymer balloon construction, tapered 4 mm CTO tips, high Rated Burst Pressure designs up to 21 atm, and non-longitudinal-growth expansion behavior for controlled post-dilation.
The company operates as a B2B medical device business selling hardware to hospitals and cardiac centers through direct enterprise field sales, with products distributed globally under a "Swiss Made" quality positioning. Revenue mechanics are based on hardware unit sales of devices, with pricing negotiated through institutional purchasing contracts; no public pricing, revenue, or funding figures are disclosed. Acrostak serves interventional cardiologists as its primary customer persona and hospitals/specialized cardiac centers as institutional buyers, with the company noting 20+ years of strategic partnerships with leading hospitals and renowned cardiologists worldwide. Corporate structure includes a wholly-owned operating subsidiary, Acrostak Maroc SA, supporting either manufacturing or regional distribution presence outside Switzerland. Co-founder Eric Raemy remains associated with the firm, and the employee count falls in the 11-50 range, indicating a focused specialist operation rather than a scaled enterprise.
Acrostak firmographics
Firmographics- Name
- Acrostak
- Legal name
- Acrostak (Schweiz) AG
- Website
- https://acrostak.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Acrostak is a Swiss medical device company that designs and manufactures specialized balloon catheters and microcatheters for interventional cardiologists performing PCI and chronic total occlusion procedures worldwide.
- Ownership category
- akta.pro rank
Acrostak industry classification
Industry- Product category
- Interventional Cardiology Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
Keywords
Where Acrostak is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Acrostak business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of interventional cardiology devices including CTO balloons, PTCA balloons, specialty balloons, and microcatheters to healthcare institutions and interventional cardiologists worldwide.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Acrostak product offering
Product offeringCore offering
Acrostak designs, develops, and manufactures specialized interventional cardiology medical devices — primarily balloon catheters and microcatheters — used by interventional cardiologists for chronic total occlusion (CTO) treatment, percutaneous coronary intervention (PCI), lesion preparation, and stent post-dilation. The portfolio comprises CTO Balloons, PTCA Balloons, Specialty Balloons (including a proprietary metal-free polymer platform), and Microcatheters, all manufactured under Swiss Made quality standards and sold to hospitals and cardiac centers globally.
Product overview
Acrostak is a Swiss medical device company founded in 2001 that designs, manufactures, and commercializes innovative interventional cardiology devices. The product portfolio consists of specialized balloon catheters and microcatheters organized into four categories: CTO Balloons (Across CTO, Across CTO ST) designed for chronic total occlusion treatment with high pushability and rated burst pressures; PTCA Balloons (Across HP semi-compliant, Across NC non-compliant) for pre/post dilation procedures; Specialty Balloons (Grip, Grip TT) featuring the company's innovative metal-free polymer technology for vessel preparation; and Microcatheters (M-Cath Flexy) for complex lesion access. All products are Swiss Made and meet high quality standards for interventional cardiology procedures worldwide.
Differentiator
Problem solved
Functional benefit
Products and services
- Across CTO Chronic Total Occlusion balloon catheter with 0.016" entry profile, 5F guiding catheter compatibility, 0.014" maximum guidewire size, and high Rated Burst Pressure up to 20 atm. Features a tapered 4mm long tip designed to cross highly calcified CTO lesions with confidence. Used by interventional cardiologists treating chronic total occlusions.
- Across CTO ST Specialized CTO balloon catheter designed for highly calcified Chronic Total Occlusions with 0.016" entry profile, 5F guiding catheter compatibility, and 17 atm Rated Burst Pressure. Features a 1mm short and robust tip to avoid the flaring effect in calcified lesions.
- Across HP Semi-compliant balloon catheter for pre and post dilation of calcified vessels with 0.017" entry profile, 5F guiding catheter compatibility, and high Rated Burst Pressure up to 20 atm. Suitable for controlled compliance during complex interventional procedures.
- Across NC Non-compliant balloon catheter for precise post dilation with 0.016" entry profile, 5F guiding catheter compatibility, and Rated Burst Pressure up to 21 atm. Features no longitudinal growth, no balloon deformations, and no dog boning effect for controlled expansion and exact, protected sizing.
- Grip Original metal-free polymer vessel-preparation balloon catheter. Features 0.019" entry profile, 5F guiding catheter compatibility, and high RBP up to 21 atm. The absence of metallic elements avoids complications while flexibility and material strength make distal lesions accessible.
- Grip TT Versatile polymer specialty balloon for lesion preparation and multiple indications with 0.016" entry profile, 5F guiding catheter compatibility. Features polymeric knobs to prevent watermelon seeds effect, providing stability and safety for patients and interventional cardiologists.
- M-Cath Flexy Microcatheter providing balance between trackability and pushability for treating complex lesions in both antegrade and retrograde approach. Features 1.65F entry profile, 5F guiding catheter compatibility, 0.014" maximum guidewire size, three-section braided shaft, reinforced tip, and durable hydrophilic coating. Available in 135 cm and 150 cm usable lengths.
Companies that use Acrostak
Customer profileSegments2 records
Ideal customer profiles2 records
Acrostak technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Acrostak partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Leading HospitalscoreStrategic partnerships with leading hospitals worldwide. Collaborates with renowned cardiologists for product development and clinical feedback to improve interventional cardiology solutions.
- Renowned CardiologistscoreStrategic partnerships with renowned interventional cardiologists who provide clinical expertise and feedback for product development and improvement.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Acrostak competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Global medtech leader whose Coronary & Structural Heart division offers an extensive PTCA balloon, microcatheter, and CTO portfolio directly overlapping with Acrostak's products, but as part of a much broader cardiovascular franchise.
- Boston Scientific: Boston Scientific's Interventional Cardiology division offers PTCA balloons (e.g., Emerge, Rebel), specialty balloons, and microcatheters targeting the same interventional cardiologists and CTO/complex PCI cases that Acrostak serves.
- Abbott Vascular: Abbott's vascular division competes across PTCA balloons, specialty balloons, and CTO devices (e.g., Trek, Mini Trek, Voyager), serving the same interventional cardiology customers as Acrostak with a much wider portfolio and global sales force.
Direct peers
- BIOTRONIK: German/German-Swiss medtech company with an interventional cardiology portfolio including balloon catheters and microcatheters, directly overlapping with Acrostak's PTCA and specialty balloon lines.
- Merit Medical Systems: Merit offers a broad interventional cardiology and peripheral vascular catheter portfolio including PTCA balloons (e.g., Aerostream) and microcatheters, serving many of the same hospitals and interventional cardiology customers as Acrostak.
- Terumo Interventional Systems: Terumo's interventional division offers PTCA balloons (e.g., Ryurei), specialty balloons, and microcatheters directly comparable to Acrostak's Across and M-Cath product families, sold to the same interventional cardiology customer base.
- Asahi Intecc: Japanese specialist in guidewires and microcatheters with a strong CTO franchise (e.g., Gaia, Confianza wires). Asahi is a comparable specialty interventional cardiology company with a similarly focused product portfolio.
- SIS Medical AG: Swiss-headquartered specialist in non-compliant and specialty PTCA balloons (e.g., OPN NC), positioned as one of the closest direct competitors to Acrostak in coronary balloon technology from a similar geographic and product niche.
Emerging players
- BrosMed Medical: Emerging interventional cardiology device company with PTCA balloons and specialty balloons comparable to Acrostak's portfolio, focused on growth markets and overlapping customer segments in complex PCI.
- iVascular: Spanish emerging specialist with a portfolio of PTCA balloons, specialty balloons, and microcatheters targeting the same interventional cardiology segment as Acrostak, but at a smaller scale and earlier commercialization stage in many markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Acrostak social profiles
Digital presenceAcrostak financial estimates
Financial estimateRevenue estimate
Valuation estimate
Acrostak leadership team
Management profileNumber of profiles
Profiles1 record
Acrostak subsidiaries and ownership
Company hierarchySubsidiaries1 record
Acrostak funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Acrostak M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Acrostak
What does Acrostak do?
Acrostak designs, develops, and manufactures specialized interventional cardiology medical devices — primarily balloon catheters and microcatheters — used by interventional cardiologists for chronic total occlusion (CTO) treatment, percutaneous coronary intervention (PCI), lesion preparation, and stent post-dilation. The portfolio comprises CTO Balloons, PTCA Balloons, Specialty Balloons (including a proprietary metal-free polymer platform), and Microcatheters, all manufactured under Swiss Made quality standards and sold to hospitals and cardiac centers globally.
Is Acrostak a public or private company?
Acrostak is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Acrostak founded?
Acrostak was founded in 2001. It employs 11 to 50 people.
Where is Acrostak based?
Acrostak is headquartered in Geneva, Switzerland, in the Europe region.
How does Acrostak make money?
One revenue line is on record: medical Device Sales.
Who are Acrostak's main competitors?
Broad incumbents on record are Medtronic, Boston Scientific and Abbott Vascular. Direct peers are BIOTRONIK, Merit Medical Systems, Terumo Interventional Systems, Asahi Intecc and SIS Medical AG. Emerging players are BrosMed Medical and iVascular.
Does Acrostak have an API?
No public API is recorded for Acrostak.
What industry is Acrostak in?
Acrostak's product category is Interventional Cardiology Medical Devices. Its primary akta.pro industry code is HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 339112 and its SIC code is 3841.